On the Feasibility of the Dosimetric Compliance Criteria of NRG-HN002: A Randomized Phase 2 Trial for Patients With p16-Positive, Nonsmoking-Associated, Locoregionally Advanced Oropharyngeal Cancer

Authors :: T Giaddui
J. Yu
Ping Xia
Karen Vineberg
Sue S. Yom
Ying Xiao
Anthony Doemer
F. Nunez
Martha M. Matuszak
Source :: International Journal of Radiation Oncology*Biology*Physics. 93:E326
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
Cancer
medicine.disease
Compliance (physiology)
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
business
P16 Positive

Tools